Results 191 to 200 of about 557,118 (297)

Ten‐Year Post‐traumatic Osteoarthritis Incidence Is Low After Pediatric Isolated Meniscal Surgery but Lower After Meniscal Repair Than Meniscectomy

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To examine the 5‐ and 10‐year incidence of post‐traumatic osteoarthritis (PTOA) after isolated, primary meniscal surgery differentiating between meniscal repair and meniscectomy, in pediatric patients. Methods Pediatric patients (≤16 years) undergoing primary meniscectomy or meniscal repair (2010‐2023) with ≥5‐year follow‐up were identified in ...
Annika N. Hiredesai   +6 more
wiley   +1 more source

Significant Geographic Variation in the Epidemiology and Management of Pediatric Osteochondritis Dissecans Exists Between the Asia‐Pacific and North America

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To evaluate regional variations in epidemiology, diagnostic approaches, and surgical interventions for pediatric osteochondritis dissecans (OCD) between Asia‐Pacific (APAC) and North America (NA). Methods A comprehensive search of PubMed, Scopus, and Cochrane Library databases was conducted from database inception until August 2025.
Joshua Rui Yen Wong   +4 more
wiley   +1 more source

Significant Differences in the Presentation, Diagnosis, and Management of Juvenile Osteochondritis Dissecans Exist Among Asia‐Pacific and European Surgeons

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To compare diagnostic and treatment preferences for juvenile osteochondritis dissecans between Asia‐Pacific and European surgeons. Methods Between January 2024 and July 2024, an electronic survey was distributed to orthopaedic surgeons affiliated with Pediatric Research in Sports Medicine Asia‐Pacific (n = 54 invited).
Si Jian Hui   +5 more
wiley   +1 more source

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz   +13 more
wiley   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner   +52 more
wiley   +1 more source

Distinct cell states define larval and adult body plans in a hemichordate. [PDF]

open access: yesNat Commun
Bump P   +10 more
europepmc   +1 more source

Type I Interferon Drives Dysfunction of a Distinct CD8+ HLA‐DRB1+ T Cell Subset in Systemic Lupus Erythematosus

open access: yesArthritis &Rheumatology, EarlyView.
Objective Systemic lupus erythematosus (SLE) is characterized by type I interferon (IFN) signaling and adaptive immune dysregulation. We previously identified hypomethylation of HLA‐DRB1 and STAT1 in SLE CD8+ T cells, enabling aberrant IFN‐driven HLA‐DRB1 expression and expansion of a distinct CD8+ T cell subset. This study characterized CD8+ HLA‐DRB1+
Huizhong Long   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy